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Abstract 1 
Synoptic reporting in tumour pathology is defined by (1) completeness in terms of data 2 
elements as well as (2) a specific, laboratory value-like format. Adoption of synoptic reporting 3 
leads to more complete reporting of essential parameters, improved standardization of 4 
diagnostic criteria and terminology as well as easier retrieval of information. It is therefore 5 
associated with a high degree of satisfaction among end users including surgeons and 6 
oncologists and contributes to improvement of clinical care. Furthermore, synoptic reporting 7 
is an important step towards higher levels of data capture, which facilitate data exchange and 8 
analysis for quality assurance, cancer epidemiology and clinical and basic research. 9 
Increased interest in and adoption of synoptic reporting on a global level is stimulated by the 10 
International Collaboration on Cancer Reporting (ICCR) which publishes freely available, 11 
evidence-based datasets for reporting a increasing number of different cancer types. 12 
These developments pave a path for increased future application of synoptic reporting 13 
across the entire field of oncologic medicine, where it will likely deploy similar benefits as in 14 
pathology. Given that synoptic reporting can be considered the most precise means for 15 
reporting of medical findings available, it may be predicted to be critical for the promises of 16 
precision medicine to become real. 17 
18 
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The need for complete and standardized reporting in Oncologic Pathology 19 
Oncologic pathology reports have a key role in diagnostic work-up, therapeutic management 20 
and post-therapeutic follow-up of every cancer patient. Given the multidisciplinarity of current 21 
oncologic management, it is natural that various specialists rely of different types of 22 
information. These specialists include, but are not limited to medical and radiation 23 
oncologists, surgeons, diagnostic and interventional radiologists, nuclear medicine 24 
physicians and pathologists themselves. Additional stakeholders include cancer registries, 25 
clinical researchers, biobanking experts and qualitity managers. Furthermore, it is 26 
increasingly acknowledged that patients demand access to their reports – which in turn may 27 
influence how the information therein should be presented [1]. 28 
It would require almost supranatural abilities from a pathologist to keep all these 29 
stakeholders in mind when signing out reports and to address their needs – or even to know 30 
what all of these actually are in the context of each specific cancer type, histological subtype, 31 
type of specimen, tumour stage, eligibility for (neo-) adjuvant therapies, etc.  32 
An additional level of complexity arises from the fact that is insufficient for a pathologist just 33 
to describe what they see under the microscope: Cut-offs for a biomarker to be reported as 34 
positive or negative may vary depending on the context. For different organs there may be 35 
subtle differences in the diagnostic criteria for vascular invasion or in the definition of 36 
involvement of surgical margins. Furthermore, these classifications change over time – or 37 
there may be competing classifications or definitions at a given time point. Therefore, even a 38 
report given by the hypothetical near-supranatural pathologist mentioned above might lead to 39 
confusion, when it remains unclear what the underlying classifications and criteria were. 40 
Synoptic reporting 41 
Pathologists have long acknowledged these challenges and recognized Synoptic Reporting 42 
(derived from ancient Greek “syn-opsis” – overview) as a means to address them[2]. It was 43 
realized early on that the decision process which parameters to include was critical and non-44 
trivial [3, 4]. Among a number of institutions, which have published protocols for synoptic 45 
reports in the past, two main players have emerged in the past years. The College of 46 
American Pathologists (CAP) publishes the most comprehensive set of synoptic cancer 47 
protocols as of now [5]. Their use has been mandatory for CAP accredited laboratories which 48 
has been a major driver for synoptic reporting in the United States and internationally. More 49 
recently, an International Collaboration on Cancer Reporting (ICCR), sponsored by a variety 50 
of international pathology organizations, has been launched [6-8]. ICCR has started to 51 
publish sets of protocols for various cancer types with the aim to cover the major cancer 52 
types. Both CAP and ICCR follow a strictly defined process for dataset development and 53 
consultation to ensure a broad consensus, expertise and reflection of the best evidence 54 
available.  55 
Format of Synoptic Reporting 56 
Initially, the term “synoptic” simply meant to indicate any structured format other than running 57 
text, usually with different data elements mentioned in separate lines [2]. CAP defines SR 58 
more narrowly [5], in that synoptic reports must not only encompass a set of required data 59 
elements (RDE), but also adhere to a “paired format”, where the designation of each RDE is 60 
followed by a “response”. In essence, this is the way how clinical laboratory values are 61 
reported (Table 1). Separate RDE must be displayed in separate lines. 62 
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Apart from this, CAP accepts a broad variety of possible formats and text markups. Of note, 63 
the range of acceptable formats includes low-technology implementations such as filling in 64 
and printing the protocols in Microsoft Word format of even photocopying protocols in order 65 
to fill them in manually. Similarly, the International Collaboration on Cancer Reporting (ICCR) 66 
provides its protocols in portable document format (PDF) which can be printed and filled in 67 
manually. CAP specifically permits to present the RDE in any order and to include additional 68 
data elements at each institution’s and/or pathologist’s discretion[5]. Furthermore, additional 69 
narrative sections are acceptable. 70 
Terminology: safety issues and uniformity 71 
Neither CAP, nor ICCR have published detailed information on how specific wordings are 72 
chosen for data elements or responses. A number of recurrent themes emerges, however, 73 
when comparing the various protocols and their development over time: Generally, there is a 74 
strong tendency toward uniformity within and across protocols. Positive findings, for example, 75 
are usually reported as “present” rather than “yes” or “positive”. Similarly, CAP protocols 76 
uniformly use the term “extranodal extension” rather than “extracapsular extension”.  77 
Negative findings are usually reported as “not identified” rather than “absent” along the line of 78 
the statement that “absence of evidence is not evidence of absence” and acknowledging the 79 
insight that in medicine the latter can rarely be provided. Of note, biomarkers for which the 80 
positive result reflects the normal situation are reported e.g. as “Intact nuclear expression” 81 
vs. “Loss of nuclear expression” rather than “positive”/”negative”. 82 
Different responses to one data element are usually designed not to differ only by a single 83 
word, which might be accidentally omitted and thereby invert the intended meaning, e.g.  “not 84 
identified” rather than “not present”. Also, there is a tendency towards some degree of 85 
redundancy, such as in the case of grading, i.e. “G2, moderately differentiated” rather than 86 
just “G2”. 87 
All of the above conventions aim at minimization of risks associated with misinterpretations of 88 
reports. Such considerations should be kept in mind while implementing synoptic protocols 89 
locally or translating them to different languages.  90 
Advantages of Synoptic Reporting:  91 
A major advantage of synoptic over narrative reporting is an increase in completeness of 92 
data elements, as demonstrated by a number of studies across various cancer types, 93 
including – but not limited to – colorectal, lung, breast and prostate cancer as well as 94 
cutaneous malignant melanoma [9-16]. One study of cutaneous malignant melanoma found 95 
completeness of reports to increase not only in non-specialised, but also in a specialized 96 
setting [11]. A meta-analysis on the effects of synoptic reporting [16] found an increase in 97 
completeness in 13 out of 14 studies. This in increase in completeness is critical, as lack of 98 
core data elements may affect quality of cancer care [10, 17]. Of note, the actual rates of 99 
completeness achieved by synoptic reporting varies significantly between studies, indicating 100 
that the characteristics of implementation may be an important factor. Furthermore, synoptic 101 
reporting may contribute to increased awareness of quality indicators and thereby improve 102 
quality of pathologic evaluation. Interestingly, the meta-analysis mentioned above [16] found 103 
an increase in numbers of lymph nodes obtained from colorectal cancer resections as well as 104 
a higher percentage of specimens reaching the minimum of 12 lymph nodes upon 105 
introduction of synoptic reporting. 106 
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Overall, synoptic reporting is associated with a high degree of satisfaction in pathologists, 107 
surgeons and oncologists [18, 19].  This satisfaction seems to be associated with perceived 108 
completeness of reports for the purpose of clinical decision making as well as ease of finding 109 
relevant information [18] (Figure 1).  110 
Limitations of Synoptic Reporting 111 
The overall high level of satisfaction with synoptic reporting notwithstanding, a similarly 112 
recurrent theme across various studies is that pathologists need more time to complete 113 
synoptic as compared to narrative reports [18]. Generally, however, the increment in time 114 
was moderate and considered acceptable when considering the benefits of synoptic 115 
reporting.  116 
An additional issue may be the length of reports. Most of the CAP protocol files extend over 117 
several pages, while the more compact format adopted by ICCR may be challenging to 118 
render within an existing laboratory information system. In part, increased length of reports is 119 
an intrinsic consequence of completeness in terms of RDE as well as of the synoptic format 120 
itself. Nevertheless, overly long reports can be avoided by a number of means: First, many 121 
RDE are conditional, i.e. they may be mandatory only in a subset of cases (e.g. nuclear 122 
grading does not apply to chromophobe renal cell carcinoma). In that case, it is acceptable to 123 
omit the pertinent line completely, rather than reporting the RDE as “not applicable”. Second, 124 
most CAP and ICCR protocols contain a number of optional data elements, which may or 125 
may not be reported at each pathologist’s or institution’s discretion. It may be prudent in this 126 
context, to refrain from including “everything”, but rather to keep readability of reports in 127 
mind. Along the same line, some hesitance may be advisable with regard to including 128 
additional data elements on a local basis. 129 
Finally, synoptic protocols may not fit well very specific circumstances, such as two different 130 
histologic tumour types (e.g. carcinoma and lymphoma) occurring in the same resection 131 
specimens. Usually, however, such issues can be addressed in a satisfactory manner, and 132 
the possibility to include free text provides sufficient flexibility. 133 
How to read synoptic reports 134 
In most instances, synoptic reports should be sufficiently self-explanatory in order to be well 135 
understandable to physicians with at least some understanding of the respective medical 136 
field. In particular, preferences of individual pathologists with respect to wording should be 137 
less of an issue than with narrative reports. Furthermore, as cancer protocols are 138 
continuously updated, synoptic reports will usually contain the information required for patient 139 
management in current terminology and with sufficient granularity. When very specific 140 
information is required, the notes accompanying each cancer or biomarker protocol may be a 141 
useful resource. CAP protocols contain a “Notes” section, which gives very detailed 142 
information on diagnostic criteria, cut-offs, grading schemes, etc. ICCR protocols are 143 
available in bookmarked and hyperlinked versions containing similar information. The 144 
respective documents are freely available on the CAP and ICCR websites. Ideally, a synoptic 145 
report should contain information, to which version of which protocol it refers. This is of 146 
particular relevance with regard to future users, given that classifications change over time.  147 
Synoptic reporting on the path towards higher levels of data capture 148 
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As discussed by Ellis and Srigley [20], synoptic reporting has a middle position regarding the 149 
degree to which data is structured and is classified as Level 3 in a 6-tiered system: 150 
 Level 1: Narrative report (no defined content) 151 
 Level 2: Narrative report with standardized content (e.g. by using a checklist for 152 
dictation) 153 
 Level 3: Synoptic report – adds a specific format, but not necessarily any underlying 154 
software implementation 155 
 Level 4: Synoptic report with electronic reporting tools 156 
 Level 5: Standardised structured report with underlying database structure 157 
 Level 6:  Standardised structured report with binding terminology in order to facilitate 158 
data exchange 159 
According to Ellis and Srigley, implementation of Level 3, primarily benefits immediate clinical 160 
needs, while higher levels of data capture are necessary for synoptic reporting to unfold its 161 
full potential for pathologists and secondary users. An underlying database structure will 162 
allow pathologists to easily monitor statistical distribution of findings and thereby identify 163 
potential deviations from expected frequencies, which in turn might point towards issues on a 164 
technical or interpretational level. 165 
Ultimately, linking synoptic reports and databases with a uniform terminology, such as 166 
SNOMED-CT, will allow third parties including biobanks and cancer registries to access large 167 
datasets with unprecedented granularity. 168 
Nevertheless, synoptic reporting according to Level 3 in the Ellison/Srigley classification has 169 
an important role within the path towards higher levels of data capture: It serves one 170 
particular purpose, i.e. clinicians’ needs, already very well. Furthermore, it can be 171 
implemented relatively more easily, fast and without major financial implications. Finally, it 172 
may be a very significant step on a psychological level, as it trains users to adhere to a 173 
standardized format and terminology and fosters precision in reporting.  174 
Synoptic reporting in oncology beyond pathology 175 
While the historic origin and widest application of synoptic reporting are in oncologic 176 
pathology, its concepts are spreading non-neoplastic pathology [21, 22] as well as oncologic 177 
specialities other than pathology. Main areas of application of synoptic reporting include 178 
radiology [23-27] and operative reports in surgery [28-33]. While the overall number of 179 
studies addressing the effects of synoptic reporting is considerably lower than in pathology, 180 
they tend to show similar outcomes; completeness of reports increases with the use of 181 
synoptic reporting, while at the same time the amount of non-essential information is reduced 182 
[34-36]. A web-based synoptic reporting tool for thyroid surgery was found to achieve 100% 183 
completeness of essential prognostic factors while completeness varied between 3% and 184 
>95% for various parameters in descriptive operative reports [37].  Of note, initiatives for 185 
synoptic reporting in radiology or oncologic surgery are mostly driven by single academic 186 
centres. In contrast to pathology, so far there is only a limited role of national or international 187 
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professional or scientific societies. One exception is the American Thyroid Association, which 188 
has issued a statement regarding essential elements of perioperative information in relation 189 
to thyroid surgery and endorsed use of synoptic operative reports [31].   190 
Perspective 191 
Over more than a quarter of a century, the concept of synoptic reporting in pathology has 192 
matured from local initiatives [2] to international standardization with defined processes for 193 
design and maintenance of evidence-based reporting templates which are coordinated with 194 
the World Health Organization Classification of Tumours [6, 38, 39]. Data is increasingly 195 
structured and linked to ontologies such as SNOMED-CT and LOINC [40], facilitating 196 
unprecedented levels of integration with the potential to revolutionize their use with regard to 197 
clinical care, quality assurance, as well as clinical and basic research [41]. 198 
This development paves a path for future widespread applications of synoptic reporting (and 199 
higher levels of data capture) in other fields in oncology.  Not only do the forces, which have 200 
driven this development in pathology – the need for complete, accurate and standardized 201 
information – act on all oncologic specialties, but also can synoptic reporting be predicted to 202 
be a major part of the respective solutions. Experience from pathology shows that high 203 
quality, evidence-based and timely consensus forms for reporting and their endorsement by 204 
national and international professional and scientific societies are critically important 205 
facilitators for widespread application of synoptic reporting.  206 
For precision medicine not to remain an empty promise, precision has to be the modus 207 
operandi in the entire practice of oncologic medicine and synoptic reporting is the most 208 
precise type of communication available to us.    209 
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Table 
 
Narrative Synoptic 
Upon incubation with the patient’s 
serum, immunofluorescence 
microscopy shows staining of 
neutrophils in a perinuclear pattern. 
This is still visible when the serum is 
diluted 1:320, but not at 1:640 dilution 
ANCA: positive (p-ANCA);  
 Titer 1:320 
The synoptic format of data element, paired with a response recapitulates the way 
clinical laboratory values are reported. This example of immunofluorescence illustrates 
that it would appear unusual to physicians to receive such test results in narrative text, 
even though there may be a similar type of analysis underlying the test result. 
… with lymph node metastases 
detected in 3 out of 12 lymph nodes, 
largest diameter 1.2 cm, without 
evidence of extracapsular extension …  
Number of lymph nodes submitted: 12 
Number of lymph nodes involved: 3 
Largest diameter of lymph node metastasis: 
1.2cm 
Extranodal extension: not identified 
Example of typical elements from a surgical pathology report. Most readers would likely 
find it more easy to extract a particular piece of information from the synoptic as 
compared to the narrative report.   
15% of tumour cells are positive for 
Mum-1. 
Mum-1 (immunostaining): negative 
15% of tumour cells are positive for 
p53. 
p53 (immunostaining): wildtype pattern 
15% of tumour cells are positive for Ki-
67. 
Ki-67 proliferation index: 15% 
In particular for biomarkers, specific criteria may have to be applied for interpretation of a 
given finding. 15% of stained tumour cell nuclei would not qualify for Mum-1 expression 
in the context of the Hans Algorithm for determining cell of origin in diffuse large B cell 
lymphoma. Depending on how the immunostaining is set up, 15% of nuclear p53 staining 
would likely indicate wildtype TP53. In contrast, for Ki-67 the percentage of positive 
nuclei is reported (with specific recommendations on how many nuclei to count for some 
tumour types).     
Table 1. Examples of information that might be found in laboratory or pathology reports in 
narrative and synoptic format. 
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Figure 
 
Figure 1. Color-coded representation of data elements (according to the College of American 
Pathologists template for lung cancer) in narrative (top) and synoptic (bottom) formats. Even 
when complete in terms of required data elements, narrative reports tend to be shorter than 
synoptic reports. Finding a particular piece of information, however, is easier with the 
synoptic format. As in this example, narrative reports tend to include more non-essential data 
of little clinical relevance (mild emphysematous change) than synoptic reports, while 
essential data elements are often incomplete. 
